158 related articles for article (PubMed ID: 37522346)
21. TSC/MTOR mutated renal cell carcinoma with leiomyomatous stroma is a distinct entity: a comprehensive study of 12 cases.
Tjota MY; Sharma A; Wanjari P; Fitzpatrick C; Segal J; Antic T
Hum Pathol; 2023 Apr; 134():124-133. PubMed ID: 36592877
[TBL] [Abstract][Full Text] [Related]
22. Positive GPNMB Immunostaining Differentiates Renal Cell Carcinoma With Fibromyomatous Stroma Associated With TSC1/2/MTOR Alterations From Others.
Li H; Argani P; Halper-Stromberg E; Lotan TL; Merino MJ; Reuter VE; Matoso A
Am J Surg Pathol; 2023 Nov; 47(11):1267-1273. PubMed ID: 37661807
[TBL] [Abstract][Full Text] [Related]
23. Co-existence of ESC-RCC, EVT, and LOT as synchronous and metachronous tumors in six patients with multifocal neoplasia but without clinical features of tuberous sclerosis complex.
Lerma LA; Schade GR; Tretiakova MS
Hum Pathol; 2021 Oct; 116():1-11. PubMed ID: 34153307
[TBL] [Abstract][Full Text] [Related]
24. Low-grade oncocytic tumor of kidney harboring TSC/MTOR mutation: clinicopathologic, immunohistochemical and molecular characteristics support a distinct entity.
Zhang HZ; Xia QY; Wang SY; Shi MJ; Wang SY
Virchows Arch; 2022 May; 480(5):999-1008. PubMed ID: 35099634
[TBL] [Abstract][Full Text] [Related]
25. Cathepsin K (Clone EPR19992) Demonstrates Uniformly Positive Immunoreactivity in Renal Oncocytoma, Chromophobe Renal Cell Carcinoma, and Distal Tubules.
Iakymenko OA; Delma KS; Jorda M; Kryvenko ON
Int J Surg Pathol; 2021 Sep; 29(6):600-605. PubMed ID: 33764165
[No Abstract] [Full Text] [Related]
26. Eosinophilic vacuolated tumor (EVT) of kidney demonstrates sporadic TSC/MTOR mutations: next-generation sequencing multi-institutional study of 19 cases.
Farcaş M; Gatalica Z; Trpkov K; Swensen J; Zhou M; Alaghehbandan R; Williamson SR; Magi-Galluzzi C; Gill AJ; Tretiakova M; Lopez JI; Montiel DP; Sperga M; Comperat E; Brimo F; Yilmaz A; Siadat F; Sangoi A; Gao Y; Ptákova N; Kuthi L; Pivovarcikova K; Rogala J; Agaimy A; Hartmann A; Fraune C; Rychly B; Hurnik P; Durcansky D; Bonert M; Gakis G; Michal M; Hora M; Hes O
Mod Pathol; 2022 Mar; 35(3):344-351. PubMed ID: 34521993
[TBL] [Abstract][Full Text] [Related]
27. Renal Cell Carcinoma Associated With TSC/MTOR Genomic Alterations: An Update on its Expanding Spectrum and an Approach to Clinicopathologic Work-up.
Shah RB; Mehra R
Adv Anat Pathol; 2024 Mar; 31(2):105-117. PubMed ID: 37899532
[TBL] [Abstract][Full Text] [Related]
28. Re-evaluation of 33 'unclassified' eosinophilic renal cell carcinomas in young patients.
Li Y; Reuter VE; Matoso A; Netto GJ; Epstein JI; Argani P
Histopathology; 2018 Mar; 72(4):588-600. PubMed ID: 28898443
[TBL] [Abstract][Full Text] [Related]
29. Translocation carcinomas of the kidney.
Argani P
Genes Chromosomes Cancer; 2022 May; 61(5):219-227. PubMed ID: 34704642
[TBL] [Abstract][Full Text] [Related]
30. Eosinophilic Solid and Cystic Renal Cell Carcinoma With Melanin Pigment-Expanding the Morphological Spectrum.
Aldera AP; Hes O
Int J Surg Pathol; 2022 May; 30(3):295-299. PubMed ID: 34402332
[TBL] [Abstract][Full Text] [Related]
31. mTOR eosinophilic renal cell carcinoma: a distinctive tumor characterized by mTOR mutation, loss of chromosome 1, cathepsin-K expression, and response to target therapy.
Caliò A; Marletta S; Settanni G; Rizzo M; Gobbo S; Pedron S; Stefanizzi L; Munari E; Brunelli M; Marcolini L; Pesci A; Fratoni S; Pierconti F; Raspollini MR; Marchetti A; Doglioni C; Amin MB; Porta C; Martignoni G
Virchows Arch; 2023 Dec; 483(6):821-833. PubMed ID: 37938323
[TBL] [Abstract][Full Text] [Related]
32. Sclerosing TSC1 mutated renal cell carcinoma: An unusual pattern mimicking MITF family translocation renal cell carcinoma.
Williamson SR; Cardili L; Whiteley LJ; Sanchez J; Kis O
Genes Chromosomes Cancer; 2020 Oct; 59(10):591-594. PubMed ID: 32418252
[TBL] [Abstract][Full Text] [Related]
33. Pediatric renal cell carcinoma with oncocytoid features occurring in a child after chemotherapy for cardiac leiomyosarcoma.
Dhall D; Al-Ahmadie HA; Dhall G; Shen-Schwarz S; Tickoo SK
Urology; 2007 Jul; 70(1):178.e13-5. PubMed ID: 17656235
[TBL] [Abstract][Full Text] [Related]
34. Low-grade oncocytic renal tumor (LOT): mutations in mTOR pathway genes and low expression of FOXI1.
Morini A; Drossart T; Timsit MO; Sibony M; Vasiliu V; Gimenez-Roqueplo AP; Favier J; Badoual C; Mejean A; Burnichon N; Verkarre V
Mod Pathol; 2022 Mar; 35(3):352-360. PubMed ID: 34531523
[TBL] [Abstract][Full Text] [Related]
35. Xp11 translocation renal cell carcinoma (RCC): extended immunohistochemical profile emphasizing novel RCC markers.
Argani P; Hicks J; De Marzo AM; Albadine R; Illei PB; Ladanyi M; Reuter VE; Netto GJ
Am J Surg Pathol; 2010 Sep; 34(9):1295-303. PubMed ID: 20679884
[TBL] [Abstract][Full Text] [Related]
36. [Eosinophilic solid and cystic renal cell carcinoma: clinicopathological analysis and molecular characterization].
Xia QY; Wang X; Wei X; Wang XT; Ma HH; Lu ZF; Rao Q
Zhonghua Bing Li Xue Za Zhi; 2019 Nov; 48(11):840-845. PubMed ID: 31775431
[No Abstract] [Full Text] [Related]
37. Eosinophilic solid and cystic renal cell carcinoma with TSC2 mutation: a case report and literature review.
He X; Chen Y; Tang H; Xu Y; Zhu X; Wang C; Chen Q; Guo D
Diagn Pathol; 2023 Apr; 18(1):53. PubMed ID: 37098579
[TBL] [Abstract][Full Text] [Related]
38. Eosinophilic Solid and Cystic Renal Cell Carcinoma (ESC RCC): Further Morphologic and Molecular Characterization of ESC RCC as a Distinct Entity.
Trpkov K; Abou-Ouf H; Hes O; Lopez JI; Nesi G; Comperat E; Sibony M; Osunkoya AO; Zhou M; Gokden N; Leroy X; Berney DM; Werneck Cunha I; Musto ML; Athanazio DA; Yilmaz A; Donnelly B; Hyndman E; Gill AJ; McKenney JK; Bismar TA
Am J Surg Pathol; 2017 Oct; 41(10):1299-1308. PubMed ID: 28786877
[TBL] [Abstract][Full Text] [Related]
39. Eosinophilic, Solid, and Cystic Renal Cell Carcinoma: Clinicopathologic Study of 16 Unique, Sporadic Neoplasms Occurring in Women.
Trpkov K; Hes O; Bonert M; Lopez JI; Bonsib SM; Nesi G; Comperat E; Sibony M; Berney DM; Martinek P; Bulimbasic S; Suster S; Sangoi A; Yilmaz A; Higgins JP; Zhou M; Gill AJ; Przybycin CG; Magi-Galluzzi C; McKenney JK
Am J Surg Pathol; 2016 Jan; 40(1):60-71. PubMed ID: 26414221
[TBL] [Abstract][Full Text] [Related]
40. [Expression of GPNMB in renal eosinophilic tumors and its value in differential diagnosis].
Wang Y; Hou MY; Fu Y; Meng K; Wu HY; Chen J; Xu YM; Shi J; Fan XS
Zhonghua Bing Li Xue Za Zhi; 2023 Apr; 52(4):358-363. PubMed ID: 36973196
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
